Overview
Nature's Sunshine Products Q3 net sales up 12% to $128.3 mln, beating analyst expectations
Adjusted EBITDA for Q3 rises 42% to $15.2 mln, exceeding analyst estimates
Company raises full-year outlook for 2025 net sales and adjusted EBITDA
Outlook
Natures Sunshine raises 2025 net sales forecast to $476-$480 mln from $460-$475 mln
Company increases 2025 adjusted EBITDA guidance to $47-$49 mln from $41-$45 mln
Result Drivers
DIGITAL SALES - Strategic investments in North America Digital led to a 52% increase in digital sales
ASIA-PACIFIC GROWTH - Exceptional results in Asia-Pacific driven by 30%+ growth in Japan and China
COST SAVINGS - Cost-saving initiatives increased gross margin by 200 basis points to 73.3%
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Sales | Beat | $128.30 mln | $120.30 mln (2 Analysts) |
Q3 Net Income | $5.30 mln | ||
Q3 Adjusted EBITDA | Beat | $15.20 mln | $10.49 mln (2 Analysts) |
Q3 Gross Margin | 73.30% | ||
Q3 Operating Income | $9 mln |
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the food processing peer group is "buy"
Wall Street's median 12-month price target for Nature's Sunshine Products Inc is $21.50, about 34.3% above its November 5 closing price of $14.13
The stock recently traded at 16 times the next 12-month earnings vs. a P/E of 17 three months ago
Press Release: ID:nGNX5p3vtv
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)